Optimization of the CD123 CAR T-cell scFv for the treatment of patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

被引：0
|
作者：
Fredon, M. [1 ]
Poussard, M. [1 ]
Biichle, S. [1 ]
Anna, F. [3 ]
Bonnefoy, F. [1 ]
Bole-Richard, E. [1 ]
Renosi, F. [1 ]
Caumartin, J. [3 ]
Loustau, M. [3 ]
Adotevi, O. [1 ,2 ]
Saas, P. [1 ]
Angelot-Delettre, F. [1 ]
Galaine, J. [1 ]
Garnache-Ottou, F. [1 ]
机构：
[1] UFC, BFC, EFS, UMR1098 RIGHT, F-25000 Besancon, France
[2] CHRU Jean Minjoz, F-25000 Besancon, France
[3] Invectys, F-75013 Paris, France
来源：
HUMAN GENE THERAPY | 2021年 / 32卷 / 19-20期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
P030
引用
收藏
页码：A37 / A37
页数：1
相关论文
共 50 条
  • [31] Role of tagraxofusp in treating blastic plasmacytoid dendritic cell neoplasm (BPDCN)
    Alfayez, Mansour
    Konopleva, Marina
    Pemmaraju, Naveen
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2020, 20 (02) : 115 - 123
  • [32] Treatment of rare cutaneous T-cell lymphoma and blastic plasmacytoid dendritic cell neoplasm
    Wehkamp, U.
    Weichenthal, M.
    HAUTARZT, 2017, 68 (09): : 711 - 715
  • [33] Tagraxofusp, a CD123-Targeted Therapy, in Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Results of a Landmark Clinical Trial
    Pemmaraju, Naveen
    Lane, Andrew
    Sweet, Kendra
    Stein, Anthony
    Vasu, Sumithira
    Blum, William
    Rizzieri, David
    Wang, Eunice
    Duvic, Madeleine
    Brooks, Christopher
    Sloan, J. Mark
    Rosenblat, Todd
    Akilov, Oleg
    Mughal, Tariq
    Lancet, Jeffrey
    Kantarjian, Hagop
    Konopleva, Marina
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S209 - S210
  • [34] Long-Term Outcomes in Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
    Pemmaraju, Naveen
    Kantarjian, Hagop M.
    Khoury, Joseph David
    O'Brien, Susan M.
    Cortes, Jorge E.
    Garcia-Manero, Guillermo
    Jabbour, Elias J.
    Jain, Nitin
    Alvarado, Yesid
    Duvic, Madeleine
    Aung, Phyu
    Qazilbash, Muzaffar H.
    Yin, C. Cameron
    Konoplev, Sergej Naumovich
    Patel, Keyur P.
    Pierce, Sherry
    Brandt, Mark
    Konopleva, Marina
    BLOOD, 2017, 130
  • [35] Social Media and Internet Resources for Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
    Pemmaraju, Naveen
    Gupta, Vikas
    Thompson, Michael A.
    Lane, Andrew A.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2016, 11 (06) : 462 - 467
  • [36] Social Media and Internet Resources for Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
    Naveen Pemmaraju
    Vikas Gupta
    Michael A. Thompson
    Andrew A. Lane
    Current Hematologic Malignancy Reports, 2016, 11 : 462 - 467
  • [37] Efficacy Proof of Concept for Allogeneic CD123 Targeting CAR T-Cells Against Primary Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Efficient Control of Tumor Progression in PDX Model and Potential Loss of CD123 Expression in Relapsed Disease
    Cai, Tianyu
    Black, Kathryn L.
    Naqvi, Ammar S.
    Taylor, Deanne
    Zhao, Ming
    Yuan, Qi
    Sugita, Mayumi
    Galetto, Roman
    Gouble, Agnes
    Smith, Julianne N. P.
    Cavazos, Antonio
    Han, Lina
    Zhang, Qi
    Kuruvilla, Vinitha Mary
    Ma, Helen
    Konoplev, Sergej
    Tang, Guilin
    Gu, Jun
    Su, Xiaoping
    Neelapu, Sattva S.
    Lane, Andrew A.
    Kantarjian, Hagop M.
    Guzman, Monica L.
    Pemmaraju, Naveen
    Thomas-Tikhonenko, Andrei
    Konopleva, Marina Y.
    BLOOD, 2019, 134
  • [38] Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm in Pediatric Patients With Tagraxofusp, a CD123Targeted Therapy
    Pemmaraju, Naveen
    Cuglievan, Branko
    Lasky, Joseph
    Kheradpour, Albert
    Hijiya, Nobuko
    Stein, Anthony S.
    Meshinchi, Soheil
    Mullen, Craig
    Angelucci, Emanuele
    Vinti, Luciana
    Mughal, Tariq I.
    Pawlowska, Anna
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S244 - S245
  • [39] Treatment of blastic plasmacytoid dendritic cell neoplasm
    Sullivan, Jill M.
    Rizzieri, David A.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2016, : 16 - 23
  • [40] TREATMENT OF BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM IN PEDIATRIC PATIENTS WITH TAGRAXOFUSP, A CD123-TARGETED THERAPY
    Vinti, Luciana
    Pemmaraju, Naveen
    Pawlowska, Anna
    Cuglievan, Branko
    Lasky, Joseph
    Kheradpour, Albert
    Hijiya, Nobuko
    Stein, Anthony
    Meshinchi, Soheil
    Mullen, Craig
    Mughal, Tariq
    Angelucci, Emanuele
    PEDIATRIC BLOOD & CANCER, 2022, 69 : S195 - S196
12345